Filing Flows › Myomo (MYO) › Q3 2026 › vs Q2 2026
Myomo (MYO) Q3 2026 vs Q2 2026 (quarter over quarter)
Myomo's revenue rose $626K (+5%) from $11.7M in Q2 2026 to $12.3M in Q3 2026.
Myomo, Q3 2026: revenue $12.3M (+22% year over year), operating margin -14.0%, net loss $4.2M, operating cash flow −$1.3M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $12.3M | $11.7M | $626K | +5% |
| Net loss | $4.2M | $4.0M | $211K | +5% |
| Costs & expenses | $16.6M | $15.7M | $837K | +5% |
| Operating costs | $14.1M | $14.0M | $95K | +0.7% |
| Interest & other, net | $2.4M | $1.7M | $670K | +39% |
| Income tax | $104K | $31K | $72K | +231% |
| Cost of revenue | $3.5M | $3.3M | $278K | +9% |
| Research & development | $1.8M | $1.7M | $89K | +5% |
| Sales & marketing | $5.1M | $5.3M | −$145K | -3% |
| General & admin | $3.6M | $3.7M | −$128K | -3% |
| Operating cash sources | $4.2M | $4.0M | $211K | +5% |
| Depreciation & amortization | $406K | $385K | $21K | +5% |
| Share-based compensation | $1.3M | $1.0M | $274K | +26% |
| Working capital & other | $1.2M | $650K | $554K | +85% |
| Cash used in operations | $1.3M | $1.9M | −$638K | -33% |
| Net loss absorbed | $4.2M | $4.0M | $211K | +5% |
Questions
How much did Myomo's revenue grow quarter over quarter in Q3 2026?
Myomo's revenue rose $626K (+5%) from $11.7M in Q2 2026 to $12.3M in Q3 2026.